levodopa has been researched along with Adverse Drug Event in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (22.86) | 18.7374 |
| 1990's | 3 (8.57) | 18.2507 |
| 2000's | 4 (11.43) | 29.6817 |
| 2010's | 9 (25.71) | 24.3611 |
| 2020's | 11 (31.43) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bahroo, L; Di Maria, G; Jankovic, J; Lamotte, G; Lenka, A | 1 |
| Bergmans, B; Bourgeois, P; Cras, P; De Klippel, N; Dethy, S; Franco, G; Garraux, G; Geens, K; Jacquerye, P; Jeanjean, A; Krygier, C; Supiot, F; Van der Linden, C | 1 |
| Horiguchi, S; Ito, S; Takahashi, M; Tsuji, Y | 1 |
| Chen, Y; Liu, JS; Pu, JL; Shi, DD; Zhang, BR | 1 |
| Buhmann, C; Hilker-Roggendorf, R; Höglinger, G; Koschel, J; Müller, T; Weise, D; Woitalla, D | 1 |
| LeWitt, PA; Martinez-Nunez, AE | 1 |
| Cao, S; Chen, H; Hu, X; Liang, Z; Liu, Z; Mao, W; Shao, M; Song, Z; Su, W; Tang, B; Wei, W; Wu, Y; Zhang, K | 1 |
| Baille, G; Blaise, AS; Carrière, N; Defebvre, L; Devos, D; Dujardin, K; Grolez, G; Kreisler, A; Kyheng, M; Moreau, C; Mutez, E; Seguy, D | 1 |
| Altiparmak, E; Erdoğan Küçükdağli, F; Köseoğlu, HT; Öztürk, Ö; Saltoğlu, T; Sücüllü Karadağ, Y | 1 |
| Farbman, ES; Hauser, RA; Klingler, M; Lee, A; LeWitt, PA; Oh, C; Qian, J; Rudzińska, M; Waters, CH | 1 |
| Arbelo, JM; Catalán, MIJ; Grandas, F; Mir, P; Parra, JC; Puente, V; Regidor, I; Santos-García, D; Valldeoriola, F | 1 |
| Capuano, A; Rafaniello, C; Rossi, F; Scavone, C; Sportiello, L; Stelitano, B | 1 |
| Al Hashel, JY; Damier, P; Kamel, WA | 1 |
| Baig, F; Barber, TR; Ben-Shlomo, Y; Hu, MT; Kelly, MJ; Klein, JC; Lawton, MA; Lo, C; Ruffmann, C | 1 |
| Bajwa, JA; Bhidayasiri, R; Chen, RS; Hattori, N; Jamora, RD; Jeon, B; Lee, MK; Mok, VC; Pisarnpong, A; Poewe, W; Syamsudin, T; Tan, LC; Zhang, B | 1 |
| Kaminska, M; Lin, JP; Lumsden, DE; Tomlin, S | 1 |
| Ballerini, R; Hauser, RA; Mori, A; Roberts, JW; Shulman, LM; Sussman, NM; Trugman, JM | 1 |
| Lyons, KE; Pahwa, R | 1 |
| Truong, DD | 1 |
| Amar, K; Eggert, K; Kuoppamäki, M; Leinonen, M; Luotonen, L; Nissinen, H; Oertel, W; Skogar, O | 1 |
| Antonini, A; Calandrella, D | 1 |
| Lian, XF; Luo, XD | 1 |
| Kathol, RG; Long, TD | 1 |
| Cherin, P; Colvez, A; Deville de Periere, G; Sereni, D | 1 |
| Gurwitz, JH; Rochon, PA | 1 |
| Cohen, KL | 1 |
| Dubois-Poulsen, A | 1 |
| Reus, VI | 1 |
| Anavekar, SN; Davis, HT; Tsianco, MC; Wardell, WM | 1 |
| Bossone, CM | 1 |
| Baruch, AL; Davis, C; Hodkinson, HM | 1 |
| Rowe, WS | 1 |
11 review(s) available for levodopa and Adverse Drug Event
| Article | Year |
|---|---|
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson's disease.
Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Humans; Levodopa; Parkinson Disease | 2022 |
Pharmacogenomics-a New Frontier for Individualized Treatment of Parkinson's Disease.
Topics: Antiparkinson Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Levodopa; Neurodegenerative Diseases; Parkinson Disease; Pharmacogenetics; Prospective Studies | 2023 |
Role of dopamine agonists in Parkinson's disease therapy.
Topics: Antiparkinson Agents; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Humans; Levodopa; Parkinson Disease | 2023 |
Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson's Disease.
Topics: Antiparkinson Agents; Apomorphine; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Humans; Levodopa; Parkinson Disease | 2023 |
Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease.
Topics: Antiparkinson Agents; Asian People; Drug-Related Side Effects and Adverse Reactions; Humans; Levodopa; Parkinson Disease | 2015 |
Levodopa-related wearing-off in Parkinson's disease: identification and management.
Topics: Antiparkinson Agents; Cost of Illness; Disabled Persons; Disease Progression; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Health Surveys; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Surveys and Questionnaires; Time Factors | 2009 |
Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease.
Topics: Antiparkinson Agents; Benzophenones; Drug-Related Side Effects and Adverse Reactions; Humans; Levodopa; Nitrophenols; Parkinson Disease; Tolcapone; Treatment Outcome | 2009 |
Pharmacokinetic evaluation of pramipexole.
Topics: Benzothiazoles; Dopamine Agonists; Drug Delivery Systems; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Heart Valve Diseases; Humans; Levodopa; Parkinson Disease; Pharmacogenetics; Pramipexole; Receptors, Dopamine; Restless Legs Syndrome | 2011 |
Critical review of data supporting affective disorder caused by nonpsychotropic medication.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Bipolar Disorder; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Glucocorticoids; Histamine H2 Antagonists; Humans; Levodopa | 1993 |
Optimising drug treatment for elderly people: the prescribing cascade.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzothiadiazines; Chronic Disease; Diuretics; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Levodopa; Metoclopramide; Sodium Chloride Symporter Inhibitors | 1997 |
Metabolic, endocrine, and drug-induced interference with pituitary function tests: a review.
Topics: Anorexia; Antipsychotic Agents; Depression; Diabetes Mellitus; Drug-Related Side Effects and Adverse Reactions; Endocrine System Diseases; Ethanol; Hormones; Humans; Hypokalemia; Levodopa; Liver Cirrhosis; Metabolic Diseases; Morphine; Obesity; Phenothiazines; Pituitary Function Tests; Pituitary Gland; Starvation; Uremia | 1977 |
4 trial(s) available for levodopa and Adverse Drug Event
| Article | Year |
|---|---|
A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease.
Topics: Administration, Inhalation; Aged; Carbidopa; Dopamine Agonists; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Powders; Single-Blind Method; Spirometry | 2020 |
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Purines; Severity of Illness Index; Surveys and Questionnaires; Time Factors | 2008 |
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility--an open-label, 6-week study.
Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Catechols; Drug-Related Side Effects and Adverse Reactions; Dyskinesias; Feasibility Studies; Female; Humans; Levodopa; Male; Nitriles; Parkinson Disease; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2010 |
[Effect of TCM treatment according to syndrome differentiation in enhancing curative effect and reducing side-effect of madopa].
Topics: Aged; Aged, 80 and over; Benserazide; Diagnosis, Differential; Dopamine Agents; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Female; Humans; Levodopa; Male; Medicine, Chinese Traditional; Middle Aged; Parkinson Disease; Phytotherapy; Prospective Studies; Syndrome; Treatment Outcome | 2007 |
20 other study(ies) available for levodopa and Adverse Drug Event
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effectiveness and safety of safinamide in routine clinical practice in a Belgian Parkinson's disease population: an open-label, levodopa add-on study.
Topics: Aged; Antiparkinson Agents; Belgium; Drug-Related Side Effects and Adverse Reactions; Humans; Levodopa; Parkinson Disease; Prospective Studies; Retrospective Studies | 2023 |
Safety and effectiveness of istradefylline as add-on therapy to levodopa in patients with Parkinson's disease: Final report of a post-marketing surveillance study in Japan.
Topics: Adult; Aged; Drug-Related Side Effects and Adverse Reactions; Female; Hallucinations; Humans; Japan; Levodopa; Male; Parkinson Disease; Product Surveillance, Postmarketing; Prospective Studies | 2022 |
Safety and Effectiveness of Rasagiline in Chinese Patients with Parkinson's Disease: A Prospective, Multicenter, Non-interventional Post-marketing Study.
Topics: Cohort Studies; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; East Asian People; Humans; Levodopa; Parkinson Disease; Prospective Studies; Treatment Outcome | 2023 |
Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Catheters, Indwelling; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Endoscopy, Gastrointestinal; Female; France; Gastrostomy; Gels; Humans; Infusion Pumps; Intestinal Absorption; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2020 |
Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson’s disease patients
Topics: Abdomen, Acute; Aged; Carbidopa; Catheterization; Deglutition Disorders; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Dysarthria; Dyskinesias; Endoscopy; Female; Gait; Gels; Humans; Intestines; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome; Turkey | 2021 |
Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Time Factors | 2019 |
Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System.
Topics: Adverse Drug Reaction Reporting Systems; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Gambling; Humans; Italy; Levodopa; Male; Parkinson Disease; Pramipexole | 2020 |
How do Parkinson's disease patients manage Ramadan fasting? An observational study.
Topics: Adult; Aged; Circadian Rhythm; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Fasting; Female; Follow-Up Studies; Humans; Islam; Kuwait; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Religion and Medicine; Self Care; Surveys and Questionnaires | 2019 |
Predictors of motor complications in early Parkinson's disease: A prospective cohort study.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Cohort Studies; Depression; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Proportional Hazards Models; Prospective Studies; Risk Assessment; Severity of Illness Index | 2019 |
Medication use in childhood dystonia.
Topics: Adolescent; Antiparkinson Agents; Baclofen; Child; Chloral Hydrate; Cohort Studies; Diazepam; Drug-Related Side Effects and Adverse Reactions; Dystonia; Dystonic Disorders; Female; Humans; Hypnotics and Sedatives; Levodopa; Logistic Models; Male; Muscle Relaxants, Central; Risk Factors; Trihexyphenidyl | 2016 |
Risk of syncope in the elderly and consumption of drugs: a case-control study.
Topics: Acepromazine; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Antipsychotic Agents; Case-Control Studies; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Fluoxetine; Haloperidol; Humans; Levodopa; Male; Matched-Pair Analysis; Pharmacoepidemiology; Risk; Syncope | 1997 |
[Ocular consequences of systemic therapy].
Topics: Anti-Inflammatory Agents; Antipsychotic Agents; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Eye Diseases; Glaucoma; Humans; Levodopa; Myelitis; Optic Neuritis; Phenothiazines; Syndrome; Vitamin A | 1977 |
Adverse interactions of drugs.
Topics: Anti-Bacterial Agents; Anticoagulants; Antidepressive Agents; Antihypertensive Agents; Barbiturates; Contraceptives, Oral, Synthetic; Digitalis Glycosides; Diuretics; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Ethanol; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuromuscular Nondepolarizing Agents; Salicylates; Sympathomimetics; Thyroid Hormones | 1975 |
Behavioral side effects of medical drugs.
Topics: Adrenal Cortex Hormones; Aged; Antihypertensive Agents; Antitubercular Agents; Aspirin; Behavior; Caffeine; Cimetidine; Contraceptives, Oral, Hormonal; Digitalis Glycosides; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levodopa; Male; Mental Disorders; Parasympatholytics; Placebos; Propranolol; Psychoses, Substance-Induced; Reserpine; Sympathomimetics; Thyroid Hormones | 1979 |
Postmarketing surveillance of new drugs: II. Case studies.
Topics: Azauridine; Bacteriuria; Contraceptives, Oral; Costs and Cost Analysis; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Humans; Ketamine; Levodopa; Research Design; United States; United States Food and Drug Administration; Valproic Acid | 1979 |
The liver: a pharmacologic perspective.
Topics: Acetaldehyde; Alcoholism; Chemical and Drug Induced Liver Injury; Diuretics; Drug-Related Side Effects and Adverse Reactions; Ethanol; Hepatic Encephalopathy; Humans; Inactivation, Metabolic; Lactulose; Levodopa; Liver; Liver Cirrhosis; Liver Diseases; Microsomes, Liver; Neomycin; Oxidation-Reduction; Pharmaceutical Preparations; Spironolactone; Vasopressins | 1977 |
Causes of high free-thyroxine index values in sick euthyroid elderly patients.
Topics: Atrial Fibrillation; Digitalis Glycosides; Disease; Diuretics; Drug-Related Side Effects and Adverse Reactions; Heart Failure; Humans; Levodopa; Thyroid Gland; Thyroxine | 1976 |
Some of the clinically more important side effects of drug therapy. Part 2.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Barbiturates; Carbenoxolone; Contraceptives, Oral; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Hemorrhage; Humans; Hydroxyquinolines; Levodopa; Liver; Lupus Erythematosus, Systemic; Phenothiazines; Porphyrias; Smoking; Stomach Ulcer | 1975 |